Nanology Labs

Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes.
Information